Why the study?
Does vaccination with vaccinia virus recombinants encoding measles hemagglutinin or fusion protein prevent fatal measles encephalitis in mice?
Does vaccination with vaccinia virus recombinants encoding measles hemagglutinin or fusion protein prevent fatal measles encephalitis in mice?
Vaccination with vaccinia virus recombinants encoding measles hemagglutinin or fusion protein successfully protects mice against lethal measles encephalitis.
Answers are grounded in this paper and cite their sources.
May guide measles encephalitis vaccine design; leaves open human translation and clinical testing.
Vaccinia virus recombinants encoding the hemagglutinin or fusion protein of measles virus have been constructed. Infection of cell cultures with the recombinants led to the synthesis of authentic measles proteins as judged by their electrophoretic mobility, recognition by antibodies, glycosylation, proteolytic cleavage, and presentation on the cell surface. Mice vaccinated with a single dose of the recombinant encoding the hemagglutinin protein developed antibodies capable of both inhibiting hemagglutination activity and neutralizing measles virus, whereas animals vaccinated with the recombinant encoding the fusion protein developed measles neutralizing antibodies. Mice vaccinated with either of the recombinants resisted a normally lethal intracerebral inoculation of a cell-associated measles virus subacute sclerosing panencephalitis strain.
No takes yet. Share an insight, caveat, or question.
Drillien et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: